adrenocorticotropic hormone

Preferred Label : adrenocorticotropic hormone;

MeSH definition : An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP).;

MeSH synonym : adrenocorticotropin; 1-39 acth; hormone, adrenocorticotropic; corticotropin; corticotrophin; corticotrophin (1-39); corticotropin (1-39); hormone, adrenocorticotrophic; adrenocorticotrophic hormone; acth (1-39); acth;

Registry Number MeSH : 9002-60-2;

Wikipedia link : https://en.wikipedia.org/wiki/Adrenocorticotropic hormone;

Codes EINECS : 232-659-7;

Is substance : O;

Details

Origin ID

D000324;

UMLS CUI

C0001655;

ATC code(s)
- acth [ATC Code]
- corticotropin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- corticotropin [Substance BNPC]
Currated CISMeF NLP mapping
- ACTH [ICD-11 Extension code]
- ACTH [MedDRA LLT]
- Adrenocorticotrophic hormone [ICD-11 Extension code]
- Adrenocorticotrophin [ICD-11 Extension code]
- Adrenocorticotropic hormone [MedDRA LLT]
- Adrenocorticotropic hormone (substance) [SNOMED CT concept]
- Adrenocorticotropin [FMA entity]
- Adrenocorticotropin [MedDRA LLT]
- Corticotrophin [MedDRA LLT]
- Corticotropin [ICD-11 Extension code]
- Corticotropin [FMA entity]
- Corticotropin [LOINC component]
- Corticotropin [NCIt concept]
- Corticotropin [MedDRA LLT]
- POMC wt Allele [NCIt concept]
- Recombinant Corticotropin [NCIt concept]
- adrenocorticotropic hormone [SNOMED Notion]
- obsolete adrenocorticotropin [GO term]
False automatic mappings
- AC Followed by Docetaxel/Trastuzumab Regimen [NCIt concept]
Indexing information
- BAM22 peptide [MeSH Supplementary Concept]
- GMM2 [MeSH Supplementary Concept]
- immunocorticotropin [MeSH Supplementary Concept]
Pharmacological action(s)
- hormones [MeSH Descriptor]
Record concept(s)
- adrenocorticotropic hormone [MeSH concept]
Related MeSH Supplementary Concept(s)
- 41795-Ba [MeSH Supplementary Concept]
- ACTH (1-10) [MeSH Supplementary Concept]
- ACTH (1-14) [MeSH Supplementary Concept]
- ACTH (1-16) [MeSH Supplementary Concept]
- ACTH (1-17) [MeSH Supplementary Concept]
- ACTH (1-17)-NH-(CH2)4-NH2, (Nalpha-(biotinyl-beta-Ala(1))-Lys(17))- [MeSH Supplementary Concept]
- ACTH (1-26), Cys-carboxamidomethyl(25)- [MeSH Supplementary Concept]
- ACTH (1-26), bis(Cys(25))- [MeSH Supplementary Concept]
- ACTH (1-32) [MeSH Supplementary Concept]
- ACTH (1-37) [MeSH Supplementary Concept]
- ACTH (1-38) [MeSH Supplementary Concept]
- ACTH (1-38), Phe(2)-Nle(4)- [MeSH Supplementary Concept]
- ACTH (1-38), Phe(2)-Nle(4)-iodo-Tyr(23)- [MeSH Supplementary Concept]
- ACTH (1-4) [MeSH Supplementary Concept]
- ACTH (13-24) [MeSH Supplementary Concept]
- ACTH (17-39) [MeSH Supplementary Concept]
- ACTH (25-39) [MeSH Supplementary Concept]
- ACTH (27-39) [MeSH Supplementary Concept]
- ACTH (4-10) [MeSH Supplementary Concept]
- ACTH (4-10), Phe(7)- [MeSH Supplementary Concept]
- ACTH (4-11) [MeSH Supplementary Concept]
- ACTH (4-12) [MeSH Supplementary Concept]
- ACTH (4-7) [MeSH Supplementary Concept]
- ACTH (4-7), Pro-Gly-Pro- [MeSH Supplementary Concept]
- ACTH (4-9) [MeSH Supplementary Concept]
- ACTH (5-10) [MeSH Supplementary Concept]
- ACTH (5-14) [MeSH Supplementary Concept]
- ACTH (5-8) [MeSH Supplementary Concept]
- ACTH (6-9) [MeSH Supplementary Concept]
- ACTH (7-10) [MeSH Supplementary Concept]
- ACTH (7-16)NH2 [MeSH Supplementary Concept]
- ACTH (7-38) [MeSH Supplementary Concept]
- ACTH (7-39) [MeSH Supplementary Concept]
- ACTH alpha (1-18) [MeSH Supplementary Concept]
- ACTH amide (1-10), Phe(7)- [MeSH Supplementary Concept]
- ACTH amide (1-16) [MeSH Supplementary Concept]
- ACTH amide (1-18), Gly(1)- [MeSH Supplementary Concept]
- ACTH amide (1-20), Ala(1)- [MeSH Supplementary Concept]
- ACTH amide alpha (1-18), Gly(1)- [MeSH Supplementary Concept]
- ACTH deficiency, isolated [MeSH Supplementary Concept]
- ACTH nonadecapeptidamide (1-19), (Trp(2,5,7-Bu(t)3)9)- [MeSH Supplementary Concept]
- ACTH nonadecapeptidamide (1-19), (t-butyl-Trp)(9)- [MeSH Supplementary Concept]
- ACTH nonadecapeptide (1-19), Aib(1)-Lys(17,18,19)- [MeSH Supplementary Concept]
- ACTH, 2,4-dinitro-5-azidophenylsulfenyl- [MeSH Supplementary Concept]
- ACTH, 2-nitro-4-azidophenylsulfenyl- [MeSH Supplementary Concept]
- ACTH, 2-nitro-5-azidophenylsulfenyl- [MeSH Supplementary Concept]
- ACTH, 2-nitrophenylsulfenyl- [MeSH Supplementary Concept]
- ACTH, biotinyl- [MeSH Supplementary Concept]
- ACTH, formylmethionyl- [MeSH Supplementary Concept]
- ACTH, nitrophenylsulphenyl- [MeSH Supplementary Concept]
- ACTH, thiolglycine- [MeSH Supplementary Concept]
- BIM 22015 [MeSH Supplementary Concept]
- His-Phe-Arg-Trp-Pro-Gly-Pro [MeSH Supplementary Concept]
- acethropan-S [MeSH Supplementary Concept]
- actid [MeSH Supplementary Concept]
- beta-cell tropin [MeSH Supplementary Concept]
- beta-corticotropin (1-19)-nonadecapeptide, Ser(1)-Lys(17,18)- [MeSH Supplementary Concept]
- ebiratide [MeSH Supplementary Concept]
- glutamyl-histidyl-phenylalanyl-arginyl-tryptophyl-glycyl-lysyl-prolyl-valyl-glycinamide cyclic peptide [MeSH Supplementary Concept]
- histidyl-phenylalanyl-prolyl-glycyl-proline [MeSH Supplementary Concept]
- lysyl-histidyl-phenylalanyl-arginyl-tryptophyl-glycinamide [MeSH Supplementary Concept]
- org 2766 [MeSH Supplementary Concept]
- org 31433 [MeSH Supplementary Concept]
See also
- petrosal sinus sampling [MeSH Descriptor]
- receptors, corticotropin [MeSH Descriptor]
See also (suggested by CISMeF)
- adrenocorticotropic hormone deficiency [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Adrenocorticotrophin [ICD-11 Extension code]
- Adrenocorticotropic hormone (substance) [SNOMED CT concept]
- Adrenocorticotropin [FMA entity]
- Corticotropin [LOINC Challenge]
- Corticotropin [FMA entity]
- Corticotropin [LOINC component]
- Corticotropin preparation (product) [Inactive SNOMED CT concept]
- adrenocorticotropic hormone [SNOMED Notion]
- corticotropin [ATC Code]
- corticotropin preparation [SNOMED Notion]
Validated automatic mappings to BTNT
- acth [ATC Code]
- corticotropin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients